Saudi Pharmaceutical Secures SAR 350 Million Credit Facility

SPIMACO

SPIMACO

2070.SA

0.00

On June 14, 2026, the Saudi Pharmaceutical Industries and Medical Appliances Company announced the signing of an agreement with Saudi National Bank to renew and increase Sharia-compliant credit facilities from SAR 200 million to SAR 350 million. The short-term financing, secured by promissory note, has a nine-month duration and is intended to finance working capital requirements. The funding was obtained on June 11, 2026.

Original announcement:

https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96041&anCat=1&cs=2070&locale=ar

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.